Winner of the 2011 APEX Award for Publication Excellence follow @IntMedNews
RSS Feeds
Find Us on Facebook

What Matters

Bone Mineral Density: Methinks Thou Dost Test Too Much
January 31, 2012



Bookmark and Share

Screening for osteoporosis by assessing bone mineral density (BMD) has become an integral part of the care we provide to our older patients. Medicare pays for dual-energy x-ray absorptiometry (DXA) screening every two years or more frequently if the procedure is determined to be medically necessary. Based on my discussions with colleagues, however, striking heterogeneity clearly exists in the frequency with which we obtain BMDs. How frequently do we really need to screen?

In a recent report in the New England Journal of Medicine, the Study of Osteoporotic Fractures Research Group provides clinicians with refreshingly helpful data to inform our practices (N Engl J Med. 2012;366:225-33). In a cohort of 4,957 women two transitions were evaluated: 1) from normal BMD to osteoporosis; and 2) from osteopenia to osteoporosis. The BMD “testing interval” was defined as the estimated time for 10% of women to make the transition to osteoporosis before having a hip or clinical vertebral fracture, with adjustments for estrogen use and clinical factors. Participants were stratified into normal BMD (T score, 1.00 or higher), mild osteopenia (T score 1.01 to 1.49), moderate osteopenia (T score 1.50 to 1.99), and advanced osteopenia (T score 2.00 to 2.49). The estimated BMD testing interval was 16.8 years (95% confidence interval [CI] 11.5 to 24.6) for women with normal BMD, 17.3 years (95% CI 13.9 to 21.5) for women with mild osteopenia, 4.7 years (95% CI, 4.2 to 5.2) for women with moderate osteopenia, and 1.1 years (95% CI, 1.0 to 1.3) for women with advanced osteopenia. Within a given T-score, the transition from osteopenia to osteoporosis was longer for women of younger age, higher BMI, and estrogen use. Table 3 provides an excellent reference tool for tailoring screening intervals for our patients. When the testing interval was redefined for 20% of women to make the transition from osteopenia to osteoporosis, the time estimates were 80% longer.

These findings provide some rationale, evidence-based guidelines upon which we can base our testing intervals. This will help us do our part to avoid breaking the bank in the interest of avoiding breaking a bone.

Dr. Ebbert reported having no relevant conflicts of interest.

I would like to receive The IMpulse E-Newsletter each week.


Specialty Focus
Sponsored by


calendar
May 19 - 24
Atlanta, GA
American Urological Association (AUA): Annual Meeting
May 21 - 25
Sarasota, FL
American Medical Seminars: Cardiology Update in Primary Care
May 22 - 25
Lisbon,
21st European Stroke Conference
May 23 - 27
Philadelphia, PA
American Association of Clinical Endocrinologists (AACE): Annual Meeting and Clinical Congress
May 23 - 24
Birmingham,
Primary Care 2012
May 23 - 25
National Harbor, MD
National Patient Safety Foundation (NPSF): Conference on Patient Safety
May 23 - 25
Liverpool,
Obstetric Anaesthetists' Association (OAA): Obstetric Anaesthesia 2012
May 23 - 25
Berlin,
European Federation of National Associations of Orthopaedics and Traumatology (EFORT): 13th Congress
May 24 - 27
Chicago, IL
Association for Psychological Science (APS): Annual Convention
May 24 - 27
Birmingham,
British Contact Lens Association (BCLA): Annual Clinical Conference and Exhibition
More Calendar »